The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Kauffman Michael since year 2005.
The trader's CIK number is 1364719.
At the time of this reporting, Kauffman Michael is the Chief Executive Officer of Karyopharm Therapeutics Inc. .
(stock ticker symbol KPTI).
See this page for all insider trading activities at Karyopharm Therapeutics Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-04-18 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 14.79 | 147,880 |
| 2018-04-18 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-04-09 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-04-09 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 12.48 | 124,830 |
| 2018-03-19 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-03-19 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 15.29 | 152,900 |
| 2018-03-07 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 16.15 | 161,460 |
| 2018-03-07 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-02-20 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-02-20 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 14.79 | 147,870 |
| 2018-02-07 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-02-07 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 12.51 | 125,050 |
| 2018-01-18 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-01-18 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 10.09 | 100,879 |
| 2018-01-08 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2018-01-08 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 10.08 | 100,770 |
| 2017-12-18 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2017-12-18 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 9.15 | 91,550 |
| 2017-12-07 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 10.39 | 103,900 |
| 2017-12-07 | KPTI | Karyopharm Therapeutics Inc. | Option Ex | 10,000 | .26 | 2,640 |
| 2015-01-12 | KPTI | Karyopharm Therapeutics Inc. | Sale | 50,000 | 33.00 | 1,650,000 |
| 2014-09-17 | VSTM | Verastem, Inc. | Buy | 3,000 | 9.10 | 27,300 |
| 2014-07-02 | KPTI | Karyopharm Therapeutics Inc. | Sale | 200,000 | 42.50 | 8,500,000 |
| 2014-06-17 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 40.36 | 403,640 |
| 2014-06-18 | KPTI | Karyopharm Therapeutics Inc. | Sale | 10,000 | 43.15 | 431,520 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kauffman Michael (Chief Executive Officer of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.